Dimensional Fund Advisors LP Gilead Sciences, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 10,500,457 shares of GILD stock, worth $1.14 Billion. This represents 0.3% of its overall portfolio holdings.

Number of Shares

10,500,457

Previous 11,607,602 9.54%

Holding current value

$1.14 Billion

Previous $1.07 Billion 9.74%

% of portfolio

0.3%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$89.14 - $117.41 $98.7 Million - $130 Million	-1,107,145 Reduced 9.54%	10,500,457 $1.18 Billion
Q4 2024 Feb 13, 2025	SELL	$83.95 - $97.9 $5.19 Million - $6.05 Million	-61,773 Reduced 0.53%	11,607,602 $1.07 Billion
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $83.7 Million - $106 Million	1,256,962 Added 12.07%	11,669,375 $978 Million
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $16.9 Million - $19.5 Million	268,208 Added 2.64%	10,412,413 $714 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $25.8 Million - $31.5 Million	361,010 Added 3.69%	10,144,205 $743 Million
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $21 Million - $23.9 Million	287,080 Added 3.02%	9,783,195 $793 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $30.6 Million - $33.4 Million	414,378 Added 4.56%	9,496,115 $712 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $4.75 Million - $5.41 Million	62,444 Added 0.69%	9,081,737 $700 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $3.6 Million - $4.1 Million	46,564 Added 0.52%	9,019,293 $748 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $7.24 Million - $10.4 Million	-116,113 Reduced 1.28%	8,972,729 $770 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $16.7 Million - $19.1 Million	280,256 Added 3.18%	9,088,842 $561 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $16.6 Million - $18.7 Million	286,885 Added 3.37%	8,808,586 $544 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $71.3 Million - $89.4 Million	1,231,734 Added 16.9%	8,521,701 $507 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $35.1 Million - $39.9 Million	541,329 Added 8.02%	7,289,967 $529 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $60.5 Million - $65.3 Million	894,368 Added 15.28%	6,748,638 $471 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $91.1 Million - $99.6 Million	1,435,775 Added 32.49%	5,854,270 $403 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $40.3 Million - $45.9 Million	-671,039 Reduced 13.18%	4,418,495 $286 Million
Q4 2020 Feb 25, 2021	BUY	$56.65 - $64.55 $288 Million - $329 Million	5,089,534 New	5,089,534 $296 Million

Others Institutions Holding GILD

# of Institutions

2,286

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $137B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Gilead Sciences, Inc. Transaction History